These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 12452737)

  • 1. Clinical pharmacokinetics of sertraline.
    DeVane CL; Liston HL; Markowitz JS
    Clin Pharmacokinet; 2002; 41(15):1247-66. PubMed ID: 12452737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.
    MacQueen G; Born L; Steiner M
    CNS Drug Rev; 2001; 7(1):1-24. PubMed ID: 11420570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
    Stowe ZN; Hostetter AL; Owens MJ; Ritchie JC; Sternberg K; Cohen LS; Nemeroff CB
    J Clin Psychiatry; 2003 Jan; 64(1):73-80. PubMed ID: 12590627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Care of depression in the elderly: comparative pharmacokinetics of SSRIs.
    Baumann P
    Int Clin Psychopharmacol; 1998 Sep; 13 Suppl 5():S35-43. PubMed ID: 9817619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service.
    Weigmann H; Gerek S; Zeisig A; Müller M; Härtter S; Hiemke C
    Ther Drug Monit; 2001 Aug; 23(4):410-3. PubMed ID: 11477325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
    Alderman J; Wolkow R; Chung M; Johnston HF
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):386-94. PubMed ID: 9549959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
    Murdoch D; McTavish D
    Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline pharmacokinetics and dynamics in adolescents.
    Axelson DA; Perel JM; Birmaher B; Rudolph GR; Nuss S; Bridge J; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1037-44. PubMed ID: 12218424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low.
    Heinonen E; Blennow M; Blomdahl-Wetterholm M; Hovstadius M; Nasiell J; Pohanka A; Gustafsson LL; Wide K
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1323-1331. PubMed ID: 33751155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent relapses of depression in a patient established on sertraline after taking herbal medicinal mixtures--a herb-drug interaction?
    Prasad KP; Tharangani PG; Samaranayake CN
    J Psychopharmacol; 2009 Mar; 23(2):216-9. PubMed ID: 18515463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive sertraline overdose.
    Brendel DH; Bodkin JA; Yang JM
    Ann Emerg Med; 2000 Nov; 36(5):524-6. PubMed ID: 11054208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
    Malinina EV; Zabozlaeva IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):22-4. PubMed ID: 20823825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.